Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients
G Maiolino, L Pedon, M Cesari, AC Frigo… - International journal of …, 2013 - Elsevier
Aims Antibodies to oxidized low-density lipoproteins (oxLDLAbs) are detectable in the
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients.
G Maiolino, L Pedon, M Cesari, A Frigo… - INTERNATIONAL …, 2013 - research.unipd.it
AIMS. Antibodies to oxidized low-density lipoproteins (oxLDLAbs) are detectable in the
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients
G Maiolino, L Pedon, M Cesari, AC Frigo… - International Journal of …, 2013 - infona.pl
Antibodies to oxidized low-density lipoproteins (oxLDLAbs) are detectable in the serum of
patients with and without atherosclerosis, but it is unclear if they play a pathogenic or a …
patients with and without atherosclerosis, but it is unclear if they play a pathogenic or a …
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients
G Maiolino, L Pedon, M Cesari… - International …, 2013 - internationaljournalofcardiology.com
Aims Antibodies to oxidized low-density lipoproteins (oxLDLAbs) are detectable in the
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients
G Maiolino, L Pedon, M Cesari, AC Frigo, M Barisa… - 2013 - pubmed.ncbi.nlm.nih.gov
Aims Antibodies to oxidized low-density lipoproteins (oxLDLAbs) are detectable in the
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients.
G Maiolino, L Pedon, M Cesari, AC Frigo… - … Journal of Cardiology, 2012 - europepmc.org
Aims Antibodies to oxidized low-density lipoproteins (oxLDLAbs) are detectable in the
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
[引用][C] Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients
G MAIOLINO, L PEDON, M CESARI… - International journal …, 2013 - pascal-francis.inist.fr
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term
cardiovascular mortality in high risk patients CNRS Inist Pascal-Francis CNRS Pascal and …
cardiovascular mortality in high risk patients CNRS Inist Pascal-Francis CNRS Pascal and …